Diffuse systemic sclerosis following COVID-19 infection.
Blum FR, Sampath AJ, Gilbert AL, Foulke GT.
Scand J Rheumatol. 2023 Jan;52(1):99-101. doi: 10.1080/03009742.2022.2103935. Epub 2022 Aug 10.
Clinical vignette: paraneoplastic diffuse systemic sclerosis.
Nowak K, Wright G.
Rheumatology (Oxford). 2022 Oct 6;61(10):e323. doi: 10.1093/rheumatology/keac106.
Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: A systematic literature review and meta-analysis.
Binda M, Ortolan A, Moccaldi B, Salvato M, Cuberli A, Padoan R, Doria A, Zanatta E.
Semin Arthritis Rheum. 2025 Feb;70:152606. doi: 10.1016/j.semarthrit.2024.152606. Epub 2024 Dec 3.
Treatment of early diffuse systemic sclerosis skin disease.
Frech TM, Shanmugam VK, Shah AA, Assassi S, Gordon JK, Hant FN, Hinchcliff ME, Steen V, Khanna D, Kayser C, Domsic RT.
Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):166-71. Epub 2013 Jul 23.
Rituximab in diffuse cutaneous systemic sclerosis: should we be using it today?
McQueen FM, Solanki K.
Rheumatology (Oxford). 2015 May;54(5):757-67. doi: 10.1093/rheumatology/keu463. Epub 2015 Jan 7.
[Systemic sclerosis].
Faber AM, Krieg T, Hunzelmann N.
Dermatologie (Heidelb). 2024 Mar;75(3):181-196. doi: 10.1007/s00105-024-05298-8. Epub 2024 Feb 16.
[Diffuse hyperpigmentation in systemic sclerosis].
Burmann SN, Matull J, Oellig F, Distler JHW, Kreuter A, Györfi AH.
Dermatologie (Heidelb). 2025 Jun;76(6):373-376. doi: 10.1007/s00105-025-05494-0. Epub 2025 Mar 26.
[Kidneys in diffuse systemic sclerosis].
Dębowska M, Staszków M.
Wiad Lek. 2016;69(5):717-720.
Diffuse systemic sclerosis.
CULLINAN ER.
Acta Med Scand Suppl. 1956;312:465-6. doi: 10.1111/j.0954-6820.1956.tb17039.x.
Management of pregnancy with diffuse cutaneous systemic sclerosis: a case report and literature review.
Yang L, Sun W, Yao Q.
J Int Med Res. 2021 Nov;49(11):3000605211060160. doi: 10.1177/03000605211060160.
